GlobeNewswire Press

  1. CDMO Recro Announces The Addition Of Clinical-Scale Sachet And Blister Packaging Offerings 6/2/2021

    Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, today announced that it has expanded the clinical capabilities of the company’s growing Clinical Trial Services (CTS) offerings.

  2. CDMO Berkshire Sterile Manufacturing Adds New Vacuum Decay Container Closure Integrity Testing System And Analytical Testing Instrumentation For cGMP Laboratory 5/20/2021

    Berkshire Sterile Manufacturing (BSM), a sterile filling contract manufacturer located in Lee, MA, recently expanded its laboratory capabilities through purchasing new and improved equipment for container closure integrity testing (CCIT), product identification testing, and neat testing, among others.

  3. Adverum Biotechnologies To Build New GMP Gene Therapy Manufacturing Facility In North Carolina 1/7/2021

    Adverum Biotechnologies, Inc., a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced plans for a new Good Manufacturing Practices facility in Durham, North Carolina.

  4. Oncorus To Build New GMP Viral Immunotherapy GMP Manufacturing Facility In Massachusetts 1/4/2021

    Oncorus, Inc. (Nasdaq: ONCR), a clinical stage biopharmaceutical company developing next-generation viral immunotherapies to transform outcomes for cancer patients, announced today that it has signed a 15-year lease to build a state-of-the-art, 88,000 square foot Good Manufacturing Practice (GMP) viral immunotherapy clinical manufacturing facility in Andover, Mass.

  5. Ultragenyx Announces Plans To Build Large-Scale Gene Therapy Manufacturing Facility In Massachusetts 11/9/2020

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare genetic diseases, today announced that it plans to build a new large-scale gene therapy manufacturing facility in Bedford, Massachusetts.

  6. BioNTech To Acquire GMP Manufacturing Site To Expand COVID-19 Vaccine Production Capacity In First Half 2021 9/17/2020

    BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced the signing of a share purchase agreement with Novartis AG, Basel / Switzerland to acquire their GMP certified manufacturing facility in Marburg, Germany.

  7. Adverum Biotechnologies Announces Appointment Of Thomas Kochy As Vice President, Commercial And Program Strategy 7/21/2020

    Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Thomas Kochy joined the company as vice president, commercial and program strategy.

  8. Adverum Biotechnologies Announces Appointment Of Heikki Jouttijärvi As Vice President Of Manufacturing 6/25/2020

    Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that Heikki Jouttijärvi joined the company as vice president, manufacturing.

  9. Emergent BioSolutions To Invest $75M In Canton Site And Expand Viral Vector And Gene Therapy Capability 6/18/2020

    Emergent BioSolutions (NYSE: EBS) today announced that it will further strengthen its contract development and manufacturing (CDMO) capabilities by expanding into viral vector and gene therapy.

  10. Sanofi Announces Large Investment For New Pharmaceutical Vaccine Manufacturing Center In France 6/16/2020

    Sanofi today detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future pandemic risks.